Machine learning based on blood test biomarkers predicts fast progression in advanced NSCLC patients treated with immunotherapy

Congratulations to @JianGuoZhou3 on your public disclosure, “Machine Learning Based on Blood Test Biomarkers Predicts Fast Progression in Advanced NSCLC Patients Treated with Immunotherapy.” We’re proud to facilitate your access to data #ClinicalResearch h

RT @JianGuoZhou3: Our study developed a predictive framework based on machine learning methods to identify FP in advanced NSCLC patients us…

RT @BMJOncology: Check out this important new study!

Check out this important new study!